Join to access to all OVN content. Join for Free
Season 1, Episode 4: Climbing Your Internal Everest with Samuel Blackman

Season 1, Episode 4: Climbing Your Internal Everest with Samuel Blackman


Share This Article


Summary

In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Samuel Blackman, the co-founder and head of R&D at Day One Biopharmaceuticals. Sam shares his experience trekking to Mount Everest Base Camp and the leadership insights he gained from the journey. The conversation covers topics such as vulnerability, facing fears, asking for help, and overcoming obstacles. Sam emphasizes the importance of authenticity and storytelling in leadership and offers recommendations for those seeking personal and professional growth. Overall, the episode provides valuable lessons and inspiration for leaders in the pharmaceutical industry.

In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Samuel Blackman, the co-founder and head of R&D at Day One Biopharmaceuticals. Sam shares his experience trekking to Mount Everest Base Camp and the leadership insights he gained from the journey. The conversation covers topics such as vulnerability, facing fears, asking for help, and overcoming obstacles. Sam emphasizes the importance of authenticity and storytelling in leadership and offers recommendations for those seeking personal and professional growth. Overall, the episode provides valuable lessons and inspiration for leaders in the pharmaceutical industry.

Takeaways:

-Authenticity and vulnerability are essential in leadership, allowing for deeper connections and support among team members.

-Facing fears and asking for help are signs of strength, not weakness, and can lead to personal and professional growth.

-Overcoming obstacles requires examining the situation, identifying what is holding you back, and finding creative solutions.

-Storytelling is a powerful tool in leadership, enabling effective communication and creating emotional connections. 

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Real-World Evidence in Oncology: Opportunities and Limitations
OVN Avatar Massimo Di Maio, Francesco Perrone, Pierfranco Conte

Real-World Evidence in Oncology: Opportunities and Limitations

Article
Leveraging existing data to contextualize phase II clinical trial findings in oncology
OVN Avatar E.M. Ray, L.A. Carey, K.E. Reeder-Hayes

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Article
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
OVN Avatar Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Explore OVN